United Therapeutics Corp
NASDAQ:UTHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
CITIC Securities Co Ltd
SSE:600030
|
CN |
|
SLM Corp
NASDAQ:SLM
|
US |
|
F
|
Fastenal Co
XETRA:FAS
|
US |
|
S
|
Societe Generale SA
OTC:SCGLF
|
FR |
|
GomSpace Group AB
LSE:0GE8
|
SE |
|
Kinross Gold Corp
TSX:K
|
CA |
|
Canyon Resources Ltd
ASX:CAY
|
AU |
|
A
|
Adecco Group AG
SIX:ADEN
|
CH |
|
Eni SpA
MIL:ENI
|
IT |
Wall St Price Targets
UTHR Price Targets Summary
United Therapeutics Corp
According to Wall Street analysts, the average 1-year price target for UTHR is 670.72 USD with a low forecast of 521.16 USD and a high forecast of 787.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTHR's stock price target?
Price Target
670.72
USD
According to Wall Street analysts, the average 1-year price target for UTHR is 670.72 USD with a low forecast of 521.16 USD and a high forecast of 787.5 USD.
What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.
What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 10%.
